Germany· DE-A57-c33892b843fe56f6
Latanoprost Viatris
A latanoprost product containing latanoprost, registered in Germany by Viatris Pharma Gmbh. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Latanoprost is registered in 18 of 19 countries.
Countries holding a registration under ATC S01EE01 (latanoprost), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 10 of them publish a price we can compare per daily dose
Latanoprost · ATC S01EE01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Latanoprost
- Manufacturer
- Viatris Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- S01EE01
- ATC class
- Latanoprost
- Defined daily dose
- 0.1 ml, AT
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
173 interactions on record for latanoprost.
Graded by severity as the source publishes them — 173 info. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Latanoprost · interactions on record
173 records
Same medicine, other countries
Latanoprost in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAKISTANPharmaselect International Beteiligungs GmbH, Vídeň
- SpainARULATAN 50 microgramos/ml COLIRIO EN SOLUCIONDr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
- United KingdomCatiolanze 50micrograms/ml eye drops emulsion 0.3ml unit doseSanten UK Ltd
- SwedenAkistan 50 mikrogram/ml Ögondroppar, lösningPharmaselect International Beteiligungs GmbH
- ItalyDROPLATANOMNIVISION ITALIA S.R.L.
- BelgiumCatiolanze 50 µg/mlSanten
- SwitzerlandCatiolanze
- United StatesIYUZEHThea Pharma Inc.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Akistan, Latacris
- Belgium · Latanea, Latanoprost Eg
- Bulgaria · Akistan, Ксалатан
- Cyprus · Gisolom, Latanoprost Demo
- Czechia · Akistan, Latanoprost Olikla
- Denmark · Latanoprost Genetic, Latanoprost Rivopharm
- Estonia · Glaumax, Latanoprost Actavis
- Spain · Latanest, Latanoprost Aurovitas
- Finland · Latanoprost Sandoz, Latanoprost Stada
- France · Latanoprost Bgr, Latanoprost Biogaran
- United Kingdom (Northern Ireland) · Latanoprost, Latanoprost Accord
- Greece · Latandrops, Lataneau
- Croatia · Lapovis, Latanox
- Hungary · Akistan, Laprosep
- Ireland · Latanoprost Genetic, Loravis
- Iceland · Catiolanze, Latanoprost Actavis
- Italy · Droplatan, Galaxia
- Liechtenstein · Catiolanze
- Lithuania · Latanoprost Actavis, Latanoprost Elvim
- Luxembourg · Latanea, Latanoprost Eg
- Latvia · Latanoprost Actavis, Latanoprost Elvim
- Malta · Latanoprost Genetic, Lunaris
- Netherlands · Latanea, Latanmono Conserveermiddelvrij
- Norway · Catiolanze, Ditiamgo
- Poland · Akistan, Latanoprost Genoptim
- Portugal · Enicil, Enicilfree
- Romania · Akistan, Glautan
- Sweden · Latanoprost Actavis, Latanoprost Genetic
- Slovenia · Akistan, Latanoprost Genetic
- Slovakia · Akistan, Latanoprost Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb5b53d7-d5f1-4390-aa6e-23ab1c0fd582 GET /v1/drugs/cb5b53d7-d5f1-4390-aa6e-23ab1c0fd582?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Ocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Latanoprost",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about latanoprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.